News >

Immunotherapy Success in Lung Cancer Sets Stage for Future Research

Kristi Rosa
Published: Tuesday, Oct 22, 2019

Antoinette Wozniak, MD, FACP, FASCO, associate director of clinical research, and medical oncologist, at University of Pittsburgh Medical Center Hillman Cancer Center

Antoinette Wozniak, MD, FACP, FASCO

The emergence of immunotherapy agents in stage III non–small cell lung cancer (NSCLC) as well as small cell lung cancer (SCLC) treatment has led to improved survival outcomes, notes Antoinette Wozniak, MD, FACP, FASCO.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication